Cytosorbents Corp Files 8-K
Ticker: CTSO · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Jan 6, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, corporate-filing
TL;DR
Cytosorbents filed an 8-K on Jan 6, 2025, reporting other events. Details TBD.
AI Summary
Cytosorbents Corporation filed an 8-K on January 6, 2025, reporting other events and financial statements. The filing indicates a change in the company's status or operations, though specific details of these events are not elaborated in the provided text. The company, incorporated in Delaware, is headquartered in Princeton, New Jersey.
Why It Matters
This filing signals a material event or change for Cytosorbents Corporation, requiring disclosure to investors and the public.
Risk Assessment
Risk Level: low — The filing itself is a routine disclosure and does not inherently present new risks, but the 'other events' could be significant.
Key Numbers
- 001-36792 — Commission File Number (Identifies the company's SEC filing record.)
- 98-0373793 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- January 6, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Princeton, New Jersey (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Cytosorbents Corporation in this 8-K filing?
The provided text does not specify the details of the 'Other Events' beyond listing it as an item information.
When was this 8-K filing submitted?
The filing was submitted on January 6, 2025.
What is Cytosorbents Corporation's principal executive office address?
The principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
In which state is Cytosorbents Corporation incorporated?
Cytosorbents Corporation is incorporated in Delaware.
What is the SIC code for Cytosorbents Corporation?
The Standard Industrial Classification (SIC) code is 3841, for Surgical & Medical Instruments & Apparatus.
Filing Stats: 418 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-01-06 16:31:41
Key Financial Figures
- $0.001 — e on which registered Common Stock, $0.001 par value CTSO The Nasdaq Stock Marke
Filing Documents
- tm252036d1_8k.htm (8-K) — 26KB
- tm252036d1_ex99-1.htm (EX-99.1) — 14KB
- image_001.jpg (GRAPHIC) — 34KB
- 0001104659-25-001341.txt ( ) — 260KB
- ctso-20250106.xsd (EX-101.SCH) — 3KB
- ctso-20250106_lab.xml (EX-101.LAB) — 33KB
- ctso-20250106_pre.xml (EX-101.PRE) — 22KB
- tm252036d1_8k_htm.xml (XML) — 3KB
01
Item 8.01 Other Events On January 6, 2025, CytoSorbents Corporation issued a press release announcing the opening of its new regional sales subsidiary in Dubai, United Arab Emirates.
01
Item 9.01 Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of the Company, dated January 6, 2025 104 Cover Page Interactive Data File (embedded with the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 6, 2025 CYTOSORBENTS CORPORATION By: /s/ Dr. Phillip P. Chan Name: Dr. Phillip P. Chan Title: Chief Executive Officer